BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang XZ, Wei W. CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacol Sin 2020;41:1387-94. [PMID: 32884075 DOI: 10.1038/s41401-020-00510-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Zhang J, Wang J, Chen H, Ouyang L, Wang Y. Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances and future perspectives. European Journal of Medicinal Chemistry 2022;243:114668. [DOI: 10.1016/j.ejmech.2022.114668] [Reference Citation Analysis]
2 Liu X, Wang Z, Qian H, Tao W, Zhang Y, Hu C, Mao W, Guo Q. Natural medicines of targeted rheumatoid arthritis and its action mechanism. Front Immunol 2022;13:945129. [DOI: 10.3389/fimmu.2022.945129] [Reference Citation Analysis]
3 Li N, Shan S, Li XQ, Chen TT, Qi M, Zhang SN, Wang ZY, Zhang LL, Wei W, Sun WY. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases. Front Immunol 2021;12:822345. [PMID: 35111168 DOI: 10.3389/fimmu.2021.822345] [Reference Citation Analysis]
4 Li Y, Jiang MY, Chen JY, Xu ZW, Zhang JW, Li T, Zhang LL, Wei W. CP-25 exerts therapeutic effects in mice with dextran sodium sulfate-induced colitis by inhibiting GRK2 translocation to downregulate the TLR4-NF-κB-NLRP3 inflammasome signaling pathway in macrophages. IUBMB Life 2021;73:1406-22. [PMID: 34590407 DOI: 10.1002/iub.2564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kuai J, Han C, Wei W. Potential Regulatory Roles of GRK2 in Endothelial Cell Activity and Pathological Angiogenesis. Front Immunol 2021;12:698424. [PMID: 34335610 DOI: 10.3389/fimmu.2021.698424] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Lin HL, Lin MY, Tsai CH, Wang YH, Chen CJ, Hwang SJ, Yen MH, Chiu YW. Harmonizing Formula Prescription Patterns in Patients With Chronic Kidney Disease: A Population-Based Cross-Sectional Study. Front Pharmacol 2021;12:573145. [PMID: 33995002 DOI: 10.3389/fphar.2021.573145] [Reference Citation Analysis]